Nikolaos P. Nanis

Nikolaos P. Nanis discloses dealings in Teladoc Health, Inc. to SEC (Form 4). Over a trading history stretching from 1 December 2023 to 3 September 2024, the count stands at 27 filings.

Sales make up the whole of the open-market record (8 sales, €86k). Outside the open market, there are 19 option exercises. 2024 to date brings no purchases and 7 sales.

On 4 September 2024 came the latest disclosure, an option exercise in Teladoc Health, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.